carbamazepine has been researched along with abacavir in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (5.88) | 29.6817 |
| 2010's | 30 (88.24) | 24.3611 |
| 2020's | 2 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Chen, YT; Chung, WH; Hung, SI | 1 |
| Bharadwaj, M; Illing, P; McCluskey, J; Purcell, AW; Rossjohn, J; Theodossis, A | 1 |
| Eckels, D; Profaizer, T | 1 |
| Pirmohamed, M | 1 |
| Bharadwaj, M; Burrows, SR; Chen, Z; Dudek, NL; Gras, S; Illing, PT; Kjer-Nielsen, L; Kostenko, L; McCluskey, J; Miles, JJ; Purcell, AW; Rossjohn, J; Vivian, JP; Williamson, NA | 1 |
| Brander, C; Llano, A | 1 |
| Illing, PT; McCluskey, J; Purcell, AW; Rossjohn, J; Vivian, JP | 1 |
| Kaniwa, N; Saito, Y | 1 |
| Chao, L; Mei, H; Pan, XC; Tan, W; Wang, Q; Zhang, YL | 1 |
| Karlin, E; Phillips, E | 1 |
| Mushiroda, T | 1 |
| Borroni, RG | 1 |
| Chen, CH; Chen, WL; Cheng, CY; Chung, WH; Deng, ST; Su, SC | 1 |
| Chen, X; Xiong, Y; Zhang, W | 1 |
| Chung, WH; Hung, SI; Mallal, S; Phillips, EJ; White, KD | 1 |
| Ostrov, DA; Park, BK; Pirmohamed, M | 1 |
| Michels, AW; Ostrov, DA | 1 |
| Banerji, A; Castells, M; Finkelman, FD; Gleich, GJ; Guttman-Yassky, E; Mallal, SA; Naisbitt, DJ; Ostrov, DA; Phillips, EJ; Pichler, WJ; Platts-Mills, TA; Plaut, M; Roujeau, JC; Schwaninger, JM; Schwartz, LB; Trepanier, LA; Wheatley, LM | 1 |
| Chung, WH; Dao, RL; Fan, WL; Hung, SI; Su, SC | 1 |
| Becquemont, L; Negrini, S | 1 |
| Adler, NR; Aung, AK; Ergen, EN; Goh, MSY; Phillips, EJ; Trubiano, J | 1 |
| Fricke-Galindo, I; LLerena, A; López-López, M | 1 |
| Dimas, K; Gerogianni, K; Tsezou, A | 1 |
| Carr, DF; Jones, AR; Ramsbottom, KA; Rigden, DJ | 1 |
| Barbaud, A; Bigliardi, P; Bircher, AJ; Broyles, A; Chang, YS; Chung, WH; Lehloenya, R; Mockenhaupt, M; Peter, J; Phillips, EJ; Pirmohamed, M; Roujeau, JC; Shear, NH; Tanno, LK; Trubiano, J; Valluzzi, R | 1 |
| Krebs, K; Lauschke, VM; Milani, L; Zhou, Y | 1 |
| Corsini, E; Galbiati, V; Iulini, M; Maddalon, A; Marinovich, M | 1 |
21 review(s) available for carbamazepine and abacavir
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Human leukocyte antigens and drug hypersensitivity.
Topics: Allopurinol; Carbamazepine; Dideoxynucleosides; Drug Eruptions; Drug Hypersensitivity; Genetic Predisposition to Disease; HLA Antigens; HLA-B Antigens; Humans; Pharmacogenetics; Stevens-Johnson Syndrome | 2007 |
Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex.
Topics: Alleles; Allopurinol; Carbamazepine; Dideoxynucleosides; Drug Hypersensitivity; HLA Antigens; Humans; Major Histocompatibility Complex; Pharmacogenetics; Polymorphism, Genetic; T-Lymphocytes | 2012 |
HLA alleles and drug hypersensitivity reactions.
Topics: Alleles; Allopurinol; Anti-HIV Agents; Carbamazepine; Dideoxynucleosides; Drug Hypersensitivity; Gene Frequency; Genetic Testing; HLA-B Antigens; HLA-B15 Antigen; Humans; Pharmacogenetics; Stevens-Johnson Syndrome | 2012 |
Human leukocyte antigen-associated drug hypersensitivity.
Topics: Animals; Anti-HIV Agents; Anticonvulsants; Antigen Presentation; Autoantigens; Carbamazepine; Dideoxynucleosides; Drug Hypersensitivity; HIV Infections; HLA Antigens; Humans; Peptide Fragments; Protein Binding; Seizures; Skin | 2013 |
Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
Topics: Alleles; Allopurinol; Amoxicillin-Potassium Clavulanate Combination; Azetidines; Benzylamines; Carbamazepine; Chemical and Drug Induced Liver Injury; Diclofenac; Dideoxynucleosides; Drug Hypersensitivity; Floxacillin; Genetic Markers; HLA Antigens; HLA-A Antigens; HLA-B Antigens; HLA-DQ alpha-Chains; Humans; Lapatinib; Pharmacogenetics; Quinazolines; Skin; Stevens-Johnson Syndrome; Ticlopidine | 2013 |
[The associations between idiosyncratic adverse drug reactions and HLA alleles and their underlying mechanism].
Topics: Alleles; Allopurinol; Anti-HIV Agents; Anticonvulsants; Carbamazepine; Dideoxynucleosides; Drug Hypersensitivity Syndrome; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Genome-Wide Association Study; HLA Antigens; HLA-B Antigens; HLA-B15 Antigen; Humans; Stevens-Johnson Syndrome | 2013 |
Genotyping for severe drug hypersensitivity.
Topics: Allopurinol; Amoxicillin-Potassium Clavulanate Combination; Carbamazepine; Dideoxynucleosides; Drug Hypersensitivity; Genotype; HLA-B Antigens; Humans; Nevirapine; Pharmacogenetics; Protein Conformation; Stevens-Johnson Syndrome | 2014 |
[Future direction of pharmacogenomics: identification of genes associated with risk of adverse drug reactions using genome-wide association study].
Topics: Anticonvulsants; Carbamazepine; Dideoxynucleosides; Drug Eruptions; Genetic Predisposition to Disease; Genome-Wide Association Study; Genotyping Techniques; HLA Antigens; Humans; Intracellular Signaling Peptides and Proteins; Nevirapine; Pharmacogenetics; Polymorphism, Genetic; Risk | 2014 |
Pharmacogenetic markers of severe cutaneous adverse drug reactions.
Topics: Allopurinol; Anti-HIV Agents; Anticonvulsants; Biomarkers; Carbamazepine; Dideoxynucleosides; Drug Eruptions; Drug Hypersensitivity Syndrome; Enzyme Inhibitors; Genes, MHC Class I; Genome-Wide Association Study; Genotype; HLA Antigens; Humans; Nevirapine; Pharmacogenetics; Polymorphism, Single Nucleotide; Stevens-Johnson Syndrome | 2014 |
HLA associations and clinical implications in T-cell mediated drug hypersensitivity reactions: an updated review.
Topics: Alleles; Allopurinol; Carbamazepine; Dideoxynucleosides; Drug Hypersensitivity Syndrome; Gene Expression; Genetic Predisposition to Disease; HLA Antigens; Humans; Stevens-Johnson Syndrome; T-Lymphocytes | 2014 |
[Pharmacogenetic research in the association between human leukocyte antigen and adverse drug reactions].
Topics: Allopurinol; Carbamazepine; Dideoxynucleosides; Drug-Related Side Effects and Adverse Reactions; Genome-Wide Association Study; HLA Antigens; Humans; Pharmacogenetics | 2014 |
Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response.
Topics: Allopurinol; B-Lymphocytes; Carbamazepine; Dideoxynucleosides; Drug Hypersensitivity; Gene Expression Regulation; Genetic Loci; HLA Antigens; Humans; Models, Immunological; Pharmacogenetics; Stevens-Johnson Syndrome; T-Lymphocytes; Virus Diseases | 2015 |
New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivity.
Topics: Carbamazepine; Dideoxynucleosides; Drug Hypersensitivity; Gene Expression Regulation; Genetic Heterogeneity; HIV Infections; HLA Antigens; Humans; Models, Immunological; Pharmacogenetics; Receptors, Antigen, T-Cell; Stevens-Johnson Syndrome; T-Lymphocytes | 2015 |
New approaches for predicting T cell-mediated drug reactions: A role for inducible and potentially preventable autoimmunity.
Topics: Autoimmunity; Carbamazepine; Diabetes Mellitus, Type 1; Dideoxynucleosides; Drug Hypersensitivity; Gene Expression Regulation; HLA Antigens; Humans; Models, Molecular; Pharmacogenetics; Prognosis; Receptors, Antigen, T-Cell; Stevens-Johnson Syndrome; T-Lymphocytes; Virus Diseases | 2015 |
Severe Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical Implementation.
Topics: Allopurinol; Anti-HIV Agents; Anticonvulsants; Biomarkers; Carbamazepine; Dideoxynucleosides; Genetic Markers; Gout Suppressants; HLA-B Antigens; Humans; Inactivation, Metabolic; Pharmacogenetics; Precision Medicine; Prognosis; Safety-Based Drug Withdrawals; Stevens-Johnson Syndrome | 2016 |
Pharmacogenetics of hypersensitivity drug reactions.
Topics: Allopurinol; Anticonvulsants; Carbamazepine; Dideoxynucleosides; Drug Hypersensitivity; Enzyme Inhibitors; Genetic Predisposition to Disease; HLA Antigens; Humans; Pharmacogenetics; Reverse Transcriptase Inhibitors | 2017 |
Recent advances in the understanding of severe cutaneous adverse reactions.
Topics: Allopurinol; Anticonvulsants; beta-Lactams; Carbamazepine; Cephalosporins; Dideoxynucleosides; Drug Eruptions; Drug Interactions; Herpesviridae Infections; Humans; Leukocytes, Mononuclear; Pharmacogenetics; Prospective Studies; Skin Tests; T-Lymphocytes; Virus Activation; Virus Latency | 2017 |
An update on HLA alleles associated with adverse drug reactions.
Topics: Alleles; Allopurinol; Carbamazepine; Dideoxynucleosides; Drug-Related Side Effects and Adverse Reactions; Economics, Pharmaceutical; HLA Antigens; Humans; Nevirapine | 2017 |
Drug-Induced Skin Adverse Reactions: The Role of Pharmacogenomics in Their Prevention.
Topics: Alleles; Allopurinol; Anti-HIV Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Carbamazepine; Dideoxynucleosides; Drug Hypersensitivity; Gene Expression; Genetic Testing; Gout Suppressants; HLA-B Antigens; Humans; Pharmacogenetics; Skin | 2018 |
Controversies in drug allergy: Testing for delayed reactions.
Topics: Animals; Asian People; Carbamazepine; Dideoxynucleosides; HLA-B Antigens; HLA-B15 Antigen; Humans; Skin Tests; Stevens-Johnson Syndrome | 2019 |
13 other study(ies) available for carbamazepine and abacavir
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Genetics and the potential for predictive tests in adverse drug reactions.
Topics: Allopurinol; Anti-Bacterial Agents; Anti-HIV Agents; Anticonvulsants; Antimetabolites; Biomarkers; Carbamazepine; Chemical and Drug Induced Liver Injury; Dideoxynucleosides; Drug Hypersensitivity; Drug-Related Side Effects and Adverse Reactions; Genome-Wide Association Study; HLA Antigens; HLA-A Antigens; HLA-B Antigens; Humans; Immune System; Predictive Value of Tests; Stevens-Johnson Syndrome | 2012 |
Immune self-reactivity triggered by drug-modified HLA-peptide repertoire.
Topics: Antigen Presentation; Autoimmunity; Binding Sites; Blood Donors; Carbamazepine; CD8-Positive T-Lymphocytes; Dideoxynucleosides; Drug Hypersensitivity; HLA-B Antigens; Humans; Models, Molecular; Protein Conformation; Syndrome; T-Lymphocytes | 2012 |
Mechanisms involved in the Abacavir-mediated hypersensitivity syndrome.
Topics: Alleles; Anti-HIV Agents; Autoimmunity; Carbamazepine; Dideoxynucleosides; Drug Hypersensitivity; HIV Infections; HLA-B Antigens; Humans; Syndrome | 2012 |
Report from the National Institute of Allergy and Infectious Diseases workshop on drug allergy.
Topics: Carbamazepine; Dideoxynucleosides; Drug Hypersensitivity; Gene Expression; Haptens; HLA Antigens; Humans; Immunoglobulin E; National Institute of Allergy and Infectious Diseases (U.S.); Practice Guidelines as Topic; Receptors, Antigen, T-Cell; Stevens-Johnson Syndrome; Terminology as Topic; Translational Research, Biomedical; United States; Virus Diseases | 2015 |
Critical assessment of approaches for molecular docking to elucidate associations of HLA alleles with adverse drug reactions.
Topics: Alleles; Carbamazepine; Dideoxynucleosides; Drug-Related Side Effects and Adverse Reactions; HLA Antigens; Humans; Molecular Docking Simulation; Peptides; Risk Factors; Software; Structural Homology, Protein | 2018 |
Global Frequencies of Clinically Important HLA Alleles and Their Implications For the Cost-Effectiveness of Preemptive Pharmacogenetic Testing.
Topics: Alleles; Allopurinol; Asia; Carbamazepine; Cost-Benefit Analysis; Dideoxynucleosides; Drug Hypersensitivity; Europe; Genetic Testing; Genotype; HLA Antigens; Humans; Pharmacogenetics; Pharmacogenomic Testing | 2021 |
In vitro identification of drugs inducing systemic hypersensitivity reactions known in vivo to be associated with specific HLA genotypes.
Topics: B7-2 Antigen; Carbamazepine; Cell Survival; Clozapine; Dideoxynucleosides; Drug Hypersensitivity; Genotype; HLA Antigens; Humans; Intercellular Adhesion Molecule-1; Interleukin-8; Metformin; THP-1 Cells | 2020 |